Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345)Business Wire • 08/03/21
3 Reasons Why Pfizer's and Moderna's Vaccine Revenue Growth Is Just Getting StartedThe Motley Fool • 08/03/21
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA TherapeuticBusiness Wire • 08/02/21
Pfizer and Moderna hiked their COVID-19 vaccine prices in the EU after AstraZeneca lost popularity there, report saysBusiness Insider • 08/02/21
Worried About the Delta Variant? 5 Stocks to Insulate You From a COVID Market CrashThe Motley Fool • 08/01/21